Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PLRX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
26 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
85 filers reported a long position in PLRX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $7M | 6.1M | 0% |
| ADAR1 Capital Management, LLC | $6.3M | 5.5M | +113.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.8M | 2.4M | +4.2% |
| ACADIAN ASSET MANAGEMENT LLC | $2.7M | 2.4M | Unchanged |
| TWO SIGMA INVESTMENTS, LP | $2.6M | 2.3M | +0.4% |
| CITADEL ADVISORS LLC | $2.4M | 2.1M | -33.6% |
| RENAISSANCE TECHNOLOGIES LLC | $2.3M | 2M | +10.6% |
| Monaco Asset Management SAM | $2.2M | 1.9M | Unchanged |
| Lynx1 Capital Management LP | $2M | 1.8M | New |
| BML Capital Management, LLC | $1.8M | 1.5M | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.